IL6 and Alzheimer disease: In this study, we found that AD treatment decreased the levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6, IL-17A), while it increased the level of anti-inflammatory cytokine IL-10 in the plasm of AA mice.